Catalyst Crew CEO to Cancel Half of Restricted Stock for New Preferred Equity

Catalyst Crew Technologies Corp. (OTC: CCTC) announced Wednesday that its CEO, Kevin Roldan Levy, has initiated a capital restructuring plan under which he will cancel up to 50% of his restricted common stock holdings in exchange for a newly designated class of preferred equity. The move is designed to optimize the company's common equity base, enhance strategic flexibility, and align executive equity participation with broader corporate development goals.

The company, which is transitioning into an AI-driven healthcare technology firm focused on emerging markets, said the transaction is expected to contribute to a more disciplined equity framework. Management believes this will support future financing opportunities, strategic partnerships, and operational development as Catalyst Crew advances its telehealth and remote patient monitoring initiatives.

Levy stated, “This initiative reflects my long-term commitment to the Company’s strategic development and disciplined capital structure management. As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation.”

Catalyst Crew is currently finalizing the structure and designation of the new preferred equity and expects to provide additional updates as the implementation progresses. The company emphasized that the restructuring is intended to strengthen alignment between executive leadership and long-term corporate performance objectives.

The announcement comes as Catalyst Crew continues its pivot toward AI-enabled healthcare solutions, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets, particularly in Latin America. The company has not yet generated revenues from its current business direction and remains a development-stage enterprise.

Investors should note that the company's securities involve a high degree of risk, and any investment decision should be based on information contained in Catalyst Crew's filings with the U.S. Securities and Exchange Commission, available at www.sec.gov. More information about the company can be found at https://catalystcrewai.com.

Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively pursuing opportunities in telehealth, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Catalyst Crew CEO to Cancel Half of Restricted Stock for New Preferred Equity.